FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hans Orskov

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Kidneys

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Michael Madsen; Niels Møller; Hans Orskov; Per Løgstrup Poulsen; Jens O L Jørgensen
Cotreatment with pegvisomant and a somatostatin analog (SA) in SA-responsive acromegalic patients.
Jannik Kruse Nielsen; Christian Born Djurhuus; Claus Gravholt; Andreas Christiansen Carus; Jacob Granild-Jensen; Hans Orskov; Jens Sandahl Christiansen
Continuous glucose monitoring in interstitial subcutaneous adipose tissue and skeletal muscle reflects excursions in cerebral cortex.
Ulrick Espelund; Troels Krarup Hansen; Kurt Højlund; Henning Beck-Nielsen; Jes Thorn Clausen; Birgit S Hansen; Hans Orskov; Jens Otto Lunde Jørgensen; Jan Frystyk
Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hans Orskov (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Michael Madsen; Niels Møller; Hans Orskov; Per Løgstrup Poulsen; Jens O L Jørgensen
Cotreatment with pegvisomant and a somatostatin analog (SA) in SA-responsive acromegalic patients.
The Journal of clinical endocrinology and metabolism 2011;96(8):2405-13.
2005: Jannik Kruse Nielsen; Christian Born Djurhuus; Claus Gravholt; Andreas Christiansen Carus; Jacob Granild-Jensen; Hans Orskov; Jens Sandahl Christiansen
Continuous glucose monitoring in interstitial subcutaneous adipose tissue and skeletal muscle reflects excursions in cerebral cortex.
Diabetes 2005;54(6):1635-9.
2005: Ulrick Espelund; Troels Krarup Hansen; Kurt Højlund; Henning Beck-Nielsen; Jes Thorn Clausen; Birgit S Hansen; Hans Orskov; Jens Otto Lunde Jørgensen; Jan Frystyk
Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects.
The Journal of clinical endocrinology and metabolism 2005;90(2):741-6.
2005: Sanne Fisker; Marianne Andersen; Hans Orskov
Diagnosis of growth hormone deficiency.
Frontiers of hormone research 2005;33():68-85.
2005: Jian-Wen Chen; Kurt Højlund; Henning Beck-Nielsen; Jens Sandahl Christiansen; Hans Orskov; Jan Frystyk
Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects.
The Journal of clinical endocrinology and metabolism 2005;90(1):366-71.
2004: Christian Skjaerbaek; Jan Frystyk; Hans Orskov; Allan Flyvbjerg
Free IGF-I, IGFBP-1, and the binary complex of IGFBP-1 and IGF-I are increased during human pregnancy.
Hormone research 2004;62(5):215-20.
2003: Jens Otto Lunde Jørgensen; Morten Krag; Jill A Kanaley; J Møller; Troels Krarup Hansen; Niels Møller; Jens Sandahl Christiansen; Hans Orskov
Exercise, hormones, and body temperature. regulation and action of GH during exercise.
Journal of endocrinological investigation 2003;26(9):838-42.
2001: Claus Gravholt; Jan Frystyk; Allan Flyvbjerg; Hans Orskov; Jens Sandahl Christiansen
Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids.
American journal of physiology. Endocrinology and metabolism 2001;280(2):E308-14.
2000: NB Andersen; Troels T Andreassen; Hans Orskov; Hans Oxlund
Growth hormone and mild exercise in combination increases markedly muscle mass and tetanic tension in old rats.
European journal of endocrinology / European Federation of Endocrine Societies 2000;143(3):409-18.
2000: Andreas Kaal; Hans Orskov; Søren Nielsen; Alberto M Pedroncelli; I Lancranjan; Peter Marbach; Jørgen Weeke
Occurrence and effects of octreotide antibodies during nasal, subcutaneous and slow release intramuscular treatment.
European journal of endocrinology / European Federation of Endocrine Societies 2000;143(3):353-61.
2000: Nina Vahl; A Juul; Jens Otto Lunde Jørgensen; Hans Orskov; Niels E Skakkebaek; Jens Sandahl Christiansen
Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study.
The Journal of clinical endocrinology and metabolism 2000;85(5):1874-81.
2000: Christian Skjaerbaek; Jan Frystyk; Andreas Kaal; Torben Laursen; Jens Møller; Jørgen Weeke; Jens Otto Lunde Jørgensen; Jens Sandahl Christiansen; Hans Orskov
Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.
Clinical endocrinology 2000;52(1):25-33.
1999: Sanne Fisker; Jens Otto Lunde Jorgensen; Nina Vahl; Hans Orskov; Jens Sandahl Christiansen
Impact of gender and androgen status on IGF-I levels in normal and GH-deficient adults.
European journal of endocrinology / European Federation of Endocrine Societies 1999;141(6):601-8.
1999: Jan Frystyk; P Ivarsen; Christian Skjaerbaek; Allan Flyvbjerg; Erling B Pedersen; Hans Orskov
Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
Kidney international 1999;56(6):2076-84.
1999: Jan Frystyk; Christian Skjaerbaek; E Vestbo; Sanne Fisker; Hans Orskov
Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
Diabetes/metabolism research and reviews 1999;15(5):314-22.
1999: Birgitte Nielsen; Henning Gronbaek; Ruth Osterby; Hans Orskov; Allan Flyvbjerg
The calcium channel blocker nitrendipine attenuates renal and glomerular hypertrophy in diabetic rats.
Experimental nephrology 1999;7(3):242-50.
1999: Carsten Heuck; Christian Skjaerbaek; Hans Orskov; Ole D Wolthers
Circadian variation in serum free ultrafiltrable insulin-like growth factor I concentrations in healthy children.
Pediatric research 1999;45(5 Pt 1):733-6.
1999: Jan Frystyk; Mehboob A Hussain; Christian Skjaerbaek; Niels Pørksen; ER Froesch; Hans Orskov
The pharmacokinetics of free insulin-like growth factor-I in healthy subjects.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1999;9(2):150-6.
1999: Peter Bygballe Johansen; J Nowak; Christian Skjaerbaek; Allan Flyvbjerg; Troels T Andreassen; Michael Wilken; Hans Orskov
Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1999;9(2):106-13.
1999: Christian Skjaerbaek; Jan Frystyk; Thorbjørn Grøfte; Allan Flyvbjerg; M S Lewitt; R C Baxter; Hans Orskov
Serum free insulin-like growth factor-I is dose-dependently decreased by methylprednisolone and related to body weight changes in rats.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1999;9(1):74-80.
1999: L Ebdrup; Sanne Fisker; H H Sørensen; M B Ranke; Hans Orskov
Variety in growth hormone determinations due to use of different immunoassays and to the interference of growth hormone-binding protein.
Hormone research 1999;51 Suppl 1():20-6.
1998: Sanne Fisker; Jens Otto Lunde Jørgensen; Hans Orskov; Jens Sandahl Christiansen
GH stimulation tests: evaluation of GH responses to heat test versus insulin-tolerance test.
European journal of endocrinology / European Federation of Endocrine Societies 1998;139(6):605-10.
1998: Jan Frystyk; Henning Grønbaek; Christian Skjaerbaek; Allan Flyvbjerg; Hans Orskov; R C Baxter
Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in rats.
Endocrinology 1998;139(10):4286-92.
1998: Sanne Fisker; L Ebdrup; Hans Orskov
Influence of growth hormone binding protein on growth hormone estimation in different immunoassays.
Scandinavian journal of clinical and laboratory investigation 1998;58(5):373-81.
1998: Henning Grønbaek; Christian Skjaerbaek; Hans Orskov; Allan Flyvbjerg
Effect of immunosuppression on kidney and serum insulin-like growth factor-I (IGF-I), IGF binding proteins, and renal growth following unilateral nephrectomy in rats.
Metabolism: clinical and experimental 1998;47(7):817-23.
1998: Christian Skjaerbaek; Jan Frystyk; Hans Orskov; Peter Kissmeyer-Nielsen; Martin Bach Jensen; Søren Laurberg; Niels Møller; Allan Flyvbjerg
Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: the possible role of insulin-like growth factor-binding protein-3 proteolysis.
The Journal of clinical endocrinology and metabolism 1998;83(7):2445-9.
1998: Jan Frystyk; Christian Skjaerbaek; J Zapf; Hans Orskov
Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
Diabetologia 1998;41(5):589-94.
1998: Sanne Fisker; Nina Vahl; Thomas B Hansen; Jens Otto Lunde Jørgensen; Claus Hagen; Hans Orskov; Jens Sandahl Christiansen
Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1998;8(2):105-12.
1998: Jens Otto Lunde Jørgensen; Nina Vahl; Thomas B Hansen; Christian Skjaerbaek; Sanne Fisker; Hans Orskov; Claus Hagen; Jens Sandahl Christiansen
Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects.
Clinical endocrinology 1998;48(4):479-86.
1998: Christian Skjaerbaek; Andreas Kaal; Jens Møller; Nina Vahl; Jørgen Weeke; Hans Orskov; Allan Flyvbjerg
No effect of growth hormone on serum insulin-like growth factor binding protein-3 proteolysis.
The Journal of clinical endocrinology and metabolism 1998;83(4):1206-10.
1998: Hans Oxlund; NB Andersen; Gitte Ortoft; Hans Orskov; Troels T Andreassen
Growth hormone and mild exercise in combination markedly enhance cortical bone formation and strength in old rats.
Endocrinology 1998;139(4):1899-904.
1998: Sanne Fisker; Jens Otto Lunde Jørgensen; Hans Orskov; Jens Sandahl Christiansen
L-arginine and insulin-tolerance tests in the diagnosis of adult growth hormone deficiency: influence of confounding factors.
Clinical endocrinology 1998;48(1):109-15.
1998: Henning Grønbaek; I Vogel; Ruth Osterby; I Lancranjan; Allan Flyvbjerg; Hans Orskov
Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes.
Kidney international 1998;53(1):173-80.
1997: N Møller; Hans Orskov
Does IGF-I therapy in insulin-dependent diabetes mellitus limit complications?
Lancet 1997;350(9086):1188-9.
1997: Jan Frystyk; Mehboob A Hussain; Christian Skjaerbaek; Ole Schmitz; Jens Sandahl Christiansen; ER Froesch; Hans Orskov
Serum free IGF-I during a hyperinsulinemic clamp following 3 days of administration of IGF-I vs. saline.
The American journal of physiology 1997;273(3 Pt 1):E507-13.
1997: Jan Frystyk; Thorbjørn Grøfte; Christian Skjaerbaek; Hans Orskov
The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults.
The Journal of clinical endocrinology and metabolism 1997;82(9):3124-7.
1997: Christian Skjaerbaek; Nina Vahl; Jan Frystyk; Thomas B Hansen; Jens Otto Lunde Jørgensen; Claus Hagen; Jens Sandahl Christiansen; Hans Orskov
Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement.
European journal of endocrinology / European Federation of Endocrine Societies 1997;137(2):132-7.
1997: Sanne Fisker; Nina Vahl; Thomas B Hansen; Jens Otto Lunde Jørgensen; C Hagen; Hans Orskov; Jens Sandahl Christiansen
Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year.
Metabolism: clinical and experimental 1997;46(7):812-7.
1997: Nina Vahl; Jens Otto Lunde Jørgensen; Christian Skjaerbaek; J D Veldhuis; Hans Orskov; Jens Sandahl Christiansen
Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults.
The American journal of physiology 1997;272(6 Pt 1):E1108-16.
1997: Henning Grønbaek; P Volmers; SF Bjørn; Ruth Osterby; Hans Orskov; Allan Flyvbjerg
Effect of GH/IGF-I deficiency on long-term renal changes and urinary albumin excretion in diabetic dwarf rats.
The American journal of physiology 1997;272(5 Pt 1):E918-24.
1997: Thorbjørn Grøfte; T Wolthers; SA Jensen; Niels Møller; Jens Otto Lunde Jørgensen; Niels Tygstrup; Hans Orskov; Hendrik Vilstrup
Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats.
Hepatology (Baltimore, Md.) 1997;25(4):964-9.
1997: Sanne Fisker; Andreas Kaal; Marcella Montini; Alberto M Pedroncelli; Giorgio Pagani; Hans Orskov
Growth hormone binding protein and growth hormone availability in acromegalic patients treated with long-acting octreotide (Sandostatin-LAR).
European journal of endocrinology / European Federation of Endocrine Societies 1997;136(1):61-6.
1997: H Grønboek; B Nielsen; Allan Flyvbjerg; Hans Orskov
Effect of graded renal ablation on kidney and serum insulin-like growth factor-I (IGF-I) and IGF binding proteins in rats: relation to compensatory renal growth.
Metabolism: clinical and experimental 1997;46(1):29-35.
1997: Sanne Fisker; Nina Vahl; J O Jørgensen; Jens Sandahl Christiansen; Hans Orskov
Abdominal fat determines growth hormone-binding protein levels in healthy nonobese adults.
The Journal of clinical endocrinology and metabolism 1997;82(1):123-8.
1996: Christian Skjaerbaek; Jan Frystyk; J Møller; Jens Sandahl Christiansen; Hans Orskov
Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults.
European journal of endocrinology / European Federation of Endocrine Societies 1996;135(6):672-7.
1996: Jan Frystyk; Christian Skjaerbaek; N Alexander; Håkan Emanuelsson; H Suryapranata; H Beyer; M Foegh; Hans Orskov
Lanreotide reduces serum free and total insulin-like growth factor-I after angioplasty.
Circulation 1996;94(10):2465-71.
1996: U H Eriksen; O Amtorp; Jens P Bagger; Håkan Emanuelsson; M Foegh; Kari Saunamäki; M Schaeffer; Per Thayssen; Hans Orskov; R E Kuntz; J J Popma
[Angiopeptin versus placebo for reductin of restenosis after PTCA treatment. A randomized, double-blind study].
Ugeskrift for laeger 1996;158(46):6605-8.
1996: Henning Grønbaek; Birgitte Nielsen; Jan Frystyk; Allan Flyvbjerg; Hans Orskov
Effect of lanreotide on local kidney IGF-I and renal growth in experimental diabetes in the rat.
Experimental nephrology 1996;4(5):295-303.
1996: Sanne Fisker; Jan Frystyk; L Skriver; E Vestbo; K K Ho; Hans Orskov
A simple, rapid immunometric assay for determination of functional and growth hormone-occupied growth hormone-binding protein in human serum.
European journal of clinical investigation 1996;26(9):779-85.
1996: S M Marshall; Klavs Würgler Hansen; Ruth Osterby; Jan Frystyk; Hans Orskov; Allan Flyvbjerg
Effects of heparin on renal morphology and albuminuria in experimental diabetes.
The American journal of physiology 1996;271(2 Pt 1):E326-32.
1996: Hans Orskov
Somatostatin, growth hormone, insulin-like growth factor-1, and diabetes: friends or foes?
Metabolism: clinical and experimental 1996;45(8 Suppl 1):91-5.
1996: T Wolthers; T Grøftne; Niels Møller; Jens Sandahl Christiansen; Hans Orskov; J Weeke; Jens Otto Lunde Jørgensen
Calorigenic effects of growth hormone: the role of thyroid hormones.
The Journal of clinical endocrinology and metabolism 1996;81(4):1416-9.
1995: Jan Frystyk; B Dinesen; Hans Orskov
Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II.
Growth regulation 1995;5(4):169-76.
1995: Allan Flyvbjerg; Alwin G P Schuller; Johan W van Neck; Cora A H Groffen; Hans Orskov; Stenvert L S Drop
Stimulation of hepatic insulin-like growth factor-binding protein-1 and -3 gene expression by octreotide in rats.
The Journal of endocrinology 1995;147(3):545-51.
1995: Henning Grønbaek; Birgitte Nielsen; Jan Frystyk; Hans Orskov; Allan Flyvbjerg
Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention.
The Journal of endocrinology 1995;147(1):95-102.
1995: Jan Frystyk; E Vestbo; Christian Skjaerbaek; C E Mogensen; Hans Orskov
Free insulin-like growth factors in human obesity.
Metabolism: clinical and experimental 1995;44(10 Suppl 4):37-44.
1995: Niels Møller; Jens Otto Lunde Jørgensen; Jens Møller; L Orskov; P Ovesen; Ole Schmitz; Jens Sandahl Christiansen; Hans Orskov
Metabolic effects of growth hormone in humans.
Metabolism: clinical and experimental 1995;44(10 Suppl 4):33-6.
1995: Jens Otto Lunde Jørgensen; Niels Møller; T Wolthers; Jens Møller; Thorbjørn Grøfte; Nina Vahl; Sanne Fisker; Hans Orskov; Jens Sandahl Christiansen
Fuel metabolism in growth hormone-deficient adults.
Metabolism: clinical and experimental 1995;44(10 Suppl 4):103-7.
1995: U H Eriksen; O Amtorp; Jens P Bagger; Håkan Emanuelsson; M Foegh; P Henningsen; Kari Saunamäki; M Schaeffer; Per Thayssen; Hans Orskov
Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty.
American heart journal 1995;130(1):1-8.
1995: Jens Otto Lunde Jørgensen; Steen Pedersen; Jens Børglum; J Frystyk; K K Ho; Jens Sandahl Christiansen; Hans Orskov; Werner Blum; Bjørn Richelsen
Serum concentrations of insulin-like growth factors (IGFs), IGF binding proteins 1 and 3 and growth hormone binding protein in obese women and the effects of growth hormone administration: a double-blind, placebo-controlled study.
European journal of endocrinology / European Federation of Endocrine Societies 1995;133(1):65-70.
1995: Henning Grønbaek; Christian Skjaerbaek; B Nielsen; Jan Frystyk; M L Foegh; Allan Flyvbjerg; Hans Orskov
Growth hormone and insulin-like growth factor-I: a suggested role in renal transplantation and graft vessel disease.
Transplantation proceedings 1995;27(3):2133-6.
1995: Niels Møller; J P Bagger; Ole Schmitz; Jens Otto Lunde Jørgensen; P Ovesen; Jens Møller; K G Alberti; Hans Orskov
Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.
The Journal of clinical endocrinology and metabolism 1995;80(6):1789-93.
1995: Søren Nielsen; Ole Schmitz; Hans Orskov; C E Mogensen
Similar insulin sensitivity in NIDDM patients with normo- and microalbuminuria.
Diabetes care 1995;18(6):834-42.
1995: Henning Grønbaek; Jan Frystyk; Hans Orskov; Allan Flyvbjerg
Effect of sodium selenite on growth, insulin-like growth factor-binding proteins and insulin-like growth factor-I in rats.
The Journal of endocrinology 1995;145(1):105-12.
1995: Henning Grønbaek; Birgitte Nielsen; Ruth Osterby; A Harris; Hans Orskov; Allan Flyvbjerg
Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats.
Diabetologia 1995;38(2):135-44.
1994: Jens Otto Lunde Jørgensen; Jens Møller; T Laursen; Hans Orskov; Jens Sandahl Christiansen; Jørgen Weeke
Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults.
Clinical endocrinology 1994;41(5):609-14.
1994: Jan Frystyk; Christian Skjaerbaek; B Dinesen; Hans Orskov
Free insulin-like growth factors (IGF-I and IGF-II) in human serum.
FEBS letters 1994;348(2):185-91.
1994: Ole Schmitz; Steen Pedersen; A Mengel; Niels Pørksen; J Bak; Niels Møller; Bjørn Richelsen; K G Alberti; Peter C Butler; Hans Orskov
Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjects.
Metabolism: clinical and experimental 1994;43(7):842-6.
1994: M Howell; Hans Orskov; Jan Frystyk; Allan Flyvbjerg; Henning Grønbaek; M Foegh
Lanreotide, a somatostatin analogue, reduces insulin-like growth factor I accumulation in proliferating aortic tissue in rabbits in vivo. A preliminary study.
European journal of endocrinology / European Federation of Endocrine Societies 1994;130(4):422-5.
1994: L B Gøtzsche; Hans Orskov
Cardiac triiodothyronine nuclear receptor binding capacities in amiodarone-treated, hypo- and hyperthyroid rats.
European journal of endocrinology / European Federation of Endocrine Societies 1994;130(3):281-90.
1994: Per Ovesen; H J Ingerslev; Hans Orskov; T Ledet
Effect of growth hormone on steroidogenesis, insulin-like growth factor-I (IGF-I) and IGF-binding protein-1 production and DNA synthesis in cultured human luteinized granulosa cells.
The Journal of endocrinology 1994;140(2):313-9.
1994: T Wolthers; Thorbjørn Grøfte; Allan Flyvbjerg; Jan Frystyk; Hendrik Vilstrup; Hans Orskov; M Foegh
Dose-dependent stimulation of insulin-like growth factor-binding protein-1 by lanreotide, a somatostatin analog.
The Journal of clinical endocrinology and metabolism 1994;78(1):141-4.
1994: Hans Orskov; T Wolthers; Thorbjørn Grøfte; Allan Flyvbjerg; Hendrik Vilstrup; O Hamberg
Somatostatin-stimulated insulin-like growth factor binding protein-1 release is abolished by hyperinsulinemia.
The Journal of clinical endocrinology and metabolism 1994;78(1):138-40.
1993: Allan Flyvbjerg; S Nielsen; M I Sheikh; Christian Jacobsen; Hans Orskov; E I Christensen
Luminal and basolateral uptake and receptor binding of IGF-I in rabbit renal proximal tubules.
The American journal of physiology 1993;265(5 Pt 2):F624-33.
1993: Jens Møller; Jens Otto Lunde Jørgensen; T Lauersen; J Frystyk; Rune Weis Naeraa; Hans Orskov; Jens Sandahl Christiansen
Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters.
Clinical endocrinology 1993;39(4):403-8.
1993: Jørgen Weeke; Hans Orskov; S E Christensen; Andreas Kaal; Christian Skjaerbaek; P Illum; J Jørgensen; E Lund; A Haubek; J H Poulsen
[Long-term treatment with octreotide of patients with acromegaly].
Ugeskrift for laeger 1993;155(34):2592-8.
1993: Hans Erik Bøtker; Niels Møller; Per Ovesen; A Mengel; Ole Schmitz; Hans Orskov; Jens P Bagger
Insulin resistance in microvascular angina (syndrome X)
Lancet 1993;342(8864):136-40.
1993: Hans Orskov; Allan Flyvbjerg; Jan Frystyk; Henning Grønbaek; M Foegh; A G Harris
IGF-1 and acute renal hypertrophy: inhibition by somatostatin analogues.
Transplantation proceedings 1993;25(2):2061-2.
1993: S M Marshall; Allan Flyvbjerg; K D Jørgensen; Jørgen Weeke; Hans Orskov
Effects of growth hormone and thyroxine on kidney insulin-like growth factor-I and renal growth in hypophysectomized rats.
The Journal of endocrinology 1993;136(3):399-406.
1993: Ole Schmitz; L Orskov; S Lund; Niels Møller; Jens Sandahl Christiansen; Hans Orskov
Glucose metabolism in chronic renal failure with reference to GH treatment of uremic children.
The Journal of pediatric endocrinology 1993;6(1):53-9.
1992: A G Harris; Jørgen Weeke; S E Christensen; Andreas Kaal; P Illum; Hans Orskov
Preliminary results with Sandostatin nasal powder in acromegalic patients.
Metabolism: clinical and experimental 1992;41(9 Suppl 2):72-5.
1992: Hans Orskov; Allan Flyvbjerg; Jan Frystyk; T Ledet; N Møller; S E Christensen; A G Harris
Octreotide and diabetes: theoretical and experimental aspects.
Metabolism: clinical and experimental 1992;41(9 Suppl 2):66-71.
1992: S E Christensen; Jørgen Weeke; Hans Orskov; Andreas Kaal; E Lund; J Jørgensen; A G Harris
Long-term efficacy and tolerability of octreotide treatment in acromegaly.
Metabolism: clinical and experimental 1992;41(9 Suppl 2):44-50.
1992: Jørgen Weeke; S E Christensen; Hans Orskov; Andreas Kaal; M M Pedersen; P Illum; A G Harris
A randomized comparison of intranasal and injectable octreotide administration in patients with acromegaly.
The Journal of clinical endocrinology and metabolism 1992;75(1):163-9.
1992: Allan Flyvbjerg; Jan Frystyk; Ruth Osterby; Hans Orskov
Kidney IGF-I and renal hypertrophy in GH-deficient diabetic dwarf rats.
The American journal of physiology 1992;262(6 Pt 1):E956-62.
1992: Allan Flyvbjerg; S M Marshall; Jan Frystyk; Ruth Rasch; Karin E Bornfeldt; H Arnqvist; P K Jensen; G Pallesen; Hans Orskov
Insulin-like growth factor I in initial renal hypertrophy in potassium-depleted rats.
The American journal of physiology 1992;262(6 Pt 2):F1023-31.
1992: Allan Flyvbjerg; U Kessler; B Dorka; B Funk; Hans Orskov; Wieland Kiess
Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats.
Diabetologia 1992;35(6):589-93.
1992: S E Christensen; Jørgen Weeke; Andreas Kaal; A G Harris; Hans Orskov
SMS 201-995 and thyroid function in acromegaly: acute, intermediate and long-term effects.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1992;24(5):237-9.
1992: Allan Flyvbjerg; S M Marshall; Jan Frystyk; Klavs Würgler Hansen; A G Harris; Hans Orskov
Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion.
Kidney international 1992;41(4):805-12.
1992: Inge Dørup; Allan Flyvbjerg; M E Everts; Hans Orskov
Effects of growth hormone on growth and muscle Na(+)-K+ pump concentration in K(+)-deficient rats.
The American journal of physiology 1992;262(4 Pt 1):E511-7.
1991: Allan Flyvbjerg; Karin E Bornfeldt; Hans Orskov; H J Arnqvist
Effect of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes mellitus in rats.
Diabetologia 1991;34(10):715-20.
1991: S M Marshall; Allan Flyvbjerg; Jan Frystyk; L Korsgaard; Hans Orskov
Renal insulin-like growth factor I and growth hormone receptor binding in experimental diabetes and after unilateral nephrectomy in the rat.
Diabetologia 1991;34(9):632-9.
1991: Hans Orskov; S E Christensen; Jørgen Weeke; Andreas Kaal; A G Harris
Effects of antibodies against octreotide in two patients with acromegaly.
Clinical endocrinology 1991;34(5):395-8.
1991: Allan Flyvbjerg; K D Jørgensen; S M Marshall; Hans Orskov
Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats.
The American journal of physiology 1991;260(4 Pt 1):E568-74.
1991: Allan Flyvbjerg; C E Mogensen; Ruth Osterby; Hans Orskov
Renal hypertrophy in experimental diabetes.
The Journal of diabetic complications 1991;5(2-3):62-4.
1991: E Lund; J Jørgensen; S E Christensen; Jørgen Weeke; Hans Orskov; A G Harris
Reduction in sella turcica volume. An effect of long-term treatment with the somatostatin analogue, SMS 201-995, in acromegalic patients.
Neuroradiology 1991;33(2):162-4.
1990: Allan Flyvbjerg; Karin E Bornfeldt; S M Marshall; H J Arnqvist; Hans Orskov
Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats.
Diabetologia 1990;33(6):334-8.
1990: M M Pedersen; S E Christensen; Jens Sandahl Christiansen; E B Pedersen; C E Mogensen; Hans Orskov
Acute effects of a somatostatin analogue on kidney function in type 1 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 1990;7(4):304-9.
1990: Allan Flyvbjerg; Hans Orskov
Kidney tissue insulin-like growth factor I and initial renal growth in diabetic rats: relation to severity of diabetes.
Acta endocrinologica 1990;122(3):374-8.
1990: Niels Møller; Jens Otto Lunde Jørgensen; Ole Schmitz; Jens Møller; J Christiansen; K G Alberti; Hans Orskov
Effects of a growth hormone pulse on total and forearm substrate fluxes in humans.
The American journal of physiology 1990;258(1 Pt 1):E86-91.
1990: Jens Otto Lunde Jørgensen; Niels Møller; torsten lauritzen; K G Alberti; Hans Orskov; Jens Sandahl Christiansen
Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.
The Journal of clinical endocrinology and metabolism 1990;70(1):207-14.
1989: Leif Thuesen; S E Christensen; Jørgen Weeke; Hans Orskov; P Henningsen
The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study.
Clinical endocrinology 1989;30(6):619-25.
1989: Allan Flyvbjerg; Jan Frystyk; O Thorlacius-Ussing; Hans Orskov
Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats.
Diabetologia 1989;32(4):261-5.
1989: L Orskov; Ole Schmitz; Jens Otto Lunde Jørgensen; J Arnfred; N Abildgaard; Jens Sandahl Christiansen; K G Alberti; Hans Orskov
Influence of growth hormone on glucose-induced glucose uptake in normal men as assessed by the hyperglycemic clamp technique.
The Journal of clinical endocrinology and metabolism 1989;68(2):276-82.
1988: J Arnfred; Ole Schmitz; Ole Hother-Nielsen; C Orskov; H Beck-Nielsen; K Hermansen; Jens Sandahl Christiansen; K G Alberti; Hans Orskov
Marked impairment of the effect of hyperglycaemia on glucose uptake and glucose production in insulin-dependent diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1988;5(8):755-60.
1988: K Hermansen; Ole Schmitz; N Boye; C K Christensen; Jens Sandahl Christiansen; K G Alberti; Hans Orskov; C E Mogensen
Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion.
Metabolism: clinical and experimental 1988;37(7):640-4.
1988: Jens Otto Lunde Jørgensen; Allan Flyvbjerg; torsten lauritzen; K G Alberti; Hans Orskov; Jens Sandahl Christiansen
Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients.
The Journal of clinical endocrinology and metabolism 1988;67(1):36-40.
1988: Ole Schmitz; J Arnfred; L Orskov; O H Nielsen; Hans Orskov; V Posborg
Influence of hyperglycemia on glucose uptake and hepatic glucose production in non-dialyzed uremic patients.
Clinical nephrology 1988;30(1):27-34.
1988: Jens Otto Lunde Jørgensen; Allan Flyvbjerg; torsten lauritzen; Hans Orskov; Jens Sandahl Christiansen
Subcutaneous degradation of biosynthetic human growth hormone in growth hormone deficient patients.
Acta endocrinologica 1988;118(1):154-8.
1988: Leif Thuesen; Jens Sandahl Christiansen; O Schmitz; N J Christensen; Hans Orskov; P Henningsen
Increased myocardial contractility during intravenous insulin infusion in type 1 (insulin-dependent) diabetic patients: an echocardiographic study.
Scandinavian journal of clinical and laboratory investigation 1988;48(3):275-84.
1988: Allan Flyvbjerg; O Thorlacius-Ussing; R Naeraa; J Ingerslev; Hans Orskov
Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats.
Diabetologia 1988;31(5):310-4.
1988: O Thorlacius-Ussing; Allan Flyvbjerg; Hans Orskov
Growth in young rats after termination of sodium selenite exposure: studies of growth hormone and somatomedin C.
Toxicology 1988;48(2):167-76.
1988: Leif Thuesen; Jens Sandahl Christiansen; Keld Sørensen; Hans Orskov; P Henningsen
Low-dose intravenous glucagon has no effect on myocardial contractility in normal man. An echocardiographic study.
Scandinavian journal of clinical and laboratory investigation 1988;48(1):71-5.
1988: O Thorlacius-Ussing; Allan Flyvbjerg; K D Jørgensen; Hans Orskov
Growth hormone restores normal growth in selenium-treated rats without increase in circulating somatomedin C.
Acta endocrinologica 1988;117(1):65-72.
1988: Leif Thuesen; S E Christensen; Jørgen Weeke; Hans Orskov; P Henningsen
A hyperkinetic heart in uncomplicated active acromegaly. Explanation of hypertension in acromegalic patients?
Acta medica Scandinavica 1988;223(4):337-43.
1987: Jens Otto Lunde Jørgensen; Allan Flyvbjerg; J Dinesen; H Lund; K G Alberti; Hans Orskov; Jens Sandahl Christiansen
Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in man. A double-blind cross-over study.
Acta endocrinologica 1987;116(3):381-6.
1987: Leif Thuesen; Jens Sandahl Christiansen; O Schmitz; N J Christensen; Hans Orskov; P Henningsen
Increased myocardial performance following acute hyperglycaemia in insulin-dependent diabetic patients. A consequence of increased peripheral blood flow?
Scandinavian journal of clinical and laboratory investigation 1987;47(6):571-9.
1987: S E Christensen; Jørgen Weeke; Hans Orskov; Niels Møller; Allan Flyvbjerg; A G Harris; E Lund; J Jørgensen
Continuous subcutaneous pump infusion of somatostatin analogue SMS 201-995 versus subcutaneous injection schedule in acromegalic patients.
Clinical endocrinology 1987;27(3):297-306.
1987: S E Christensen; Jørgen Weeke; Hans Orskov; Jens Otto Lunde Jørgensen; J Esmann; J C Doxey
Plasma growth hormone in acromegalic patients. Demonstration of highly reproducible diurnal profiles in individual patients.
Acta endocrinologica 1987;116(1):49-52.
1987: Ole Schmitz; S S Sorensen; K G Alberti; Hans Orskov; H E Hansen
Metabolic control in newly kidney transplanted insulin-dependent diabetics: improvement by insulin pump treatment (CSII).
The Journal of diabetic complications 1987;1(3):81-6.
1983: K V Sørensen; S E Christensen; A P Hansen; E Pedersen; Hans Orskov
Cerebrospinal fluid somatostatin inversely correlated with disease activity in multiple sclerosis.
Lancet 1983;1(8331):988.
1983: S E Christensen; Ole Schmitz; A P Hansen; Hans Orskov
The glucose sensor. Some results and applications.
Acta medica Scandinavica. Supplementum 1983;671():121-8.